Anne Lindberg

Anne Lindberg

Auto-generated profile, based on publicly available information

Anne Lindberg

Department of public health and clinical medicine, The OLIN unit, Umeå University, Umeå, Sweden

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2003 in Respiratory Medicine
Verified
Journal Article
Closed access
BLB Lundbäck
B Lundbäck
ALA Lindberg
A Lindberg
MLM Lindström
M Lindström
ERE Rönmark
E Rönmark
AJA.C Jonsson
A.C Jonsson
KLK Larsson
K Larsson

9 September 2005 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
ESElisabeth Ståhl
Elisabeth Ståhl
ALAnne Lindberg
Anne Lindberg
SJSven-Arne Jansson
Sven-Arne Jansson
EREva Rönmark
Eva Rönmark
KSKlas Svensson
Klas Svensson
BLBo Lundbäck
Bo Lundbäck
Background: The aim of this study was to evaluate the association between health-related quality of life (HRQL) and disease severity using lung function measures. Methods: A survey was performed in subjects with COPD in Sweden. 168 subjects (70 women, mean age 64.3 years) completed the generic HRQL questionnaire, the Short Form 36 (SF-36), the disease-specific HRQL questionnaire; the St George's Respiratory Questionnaire (SGRQ), and the utility measure, the EQ-5D. The subjects were divided into four severity groups according to FEV1 per cent of predicted normal using two clinical guidelines: GOLD and BTS. Age, gender, smoking status and socio-economic group were regarded as confounders. Results: The COPD severity grades affected the SGRQ Total scores, varying from 25 to 53 (GOLD p = 0.0005) and from 25 to 45 (BTS p = 0.0023). The scores for SF-36 Physical were significantly associated with COPD severity (GOLD p = 0.0059, BTS p = 0.032). No significant association were noticed for the SF-36, Mental Component Summary scores and COPD severity. Scores for EQ-5D VAS varied from 73 to 37 (GOLD I-IV p = 0.0001) and from 73 to 50 (BTS 0-III p = 0.0007). The SGRQ Total score was significant between age groups (p = 0.0047). No significant differences in HRQL with regard to gender, smoking status or socio-economic group were noticed. Conclusion: The results show that HRQL in COPD deteriorates with disease severity and with age. These data show a relationship between HRQL and disease severity obtained by lung function.

1 February 2006 in Respiratory Medicine
Verified
Journal Article
Closed access
ALAnne Lindberg
Anne Lindberg
ABAnders Bjerg-Bäcklund
Anders Bjerg-Bäcklund
EREva Rönmark
Eva Rönmark
LLLars-Gunnar Larsson
Lars-Gunnar Larsson
BLBo Lundbäck
Bo Lundbäck

12 July 2017 in Clinical & Experimental Allergy
Verified
Journal Article
Open access
PDF file
HBHelena Backman
Helena Backman
PRPetri Räisänen
Petri Räisänen
LHLinnea Hedman
Linnea Hedman
CSCaroline Stridsman
Caroline Stridsman
MAMartin Andersson
Martin Andersson
EREva Rönmark
Eva Rönmark
Summary: Background: During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma prevalence trends among adults after 2010, especially regarding studies separating allergic asthma from non‐allergic asthma, is lacking.Objective: The aim was to estimate prevalence trends of current asthma among adults, both allergic and non‐allergic, from 1996 to 2016.Methods: Three cross‐sectional samples from the same area of Sweden, 20‐69 years, participated in surveys with the same questionnaire in 1996 (n=7104 participants, 85% response rate), 2006 (n=6165, 77%) and 2016 (n=5466, 53%), respectively. Allergic rhino‐conjunctivitis (ARC) was used as a marker for allergic sensitization to define allergic asthma.Results: The prevalence of current asthma increased from 8.4% (95% CI: 7.8‐9.0) in 1996 to 9.9% (95% CI: 9.2‐10.6) in 2006 and 10.9% (95% CI: 10.1‐11.7) in 2016 (P<.001). Allergic asthma increased from 5.0% (95% CI: 4.5‐5.5) in 1996 to 6.0% (95% CI: 5.4‐6.6) in 2006 and further to 7.3% (95% CI: 6.6‐8.0) in 2016 (P<.001), while the prevalence of non‐allergic asthma remained stable around 3.4%‐3.8%. The increase in current asthma was most pronounced among women and among the middle‐aged. Physician‐diagnosed asthma, asthma medication use and ARC also increased significantly, while the prevalence of symptoms common in asthma such as wheeze and attacks of shortness of breath decreased slightly or was stable. The prevalence of current smoking decreased from 27.4% in 1996 to 12.3% in 2016.Conclusions and Clinical Relevance: The prevalence of allergic asthma increased from 1996 to 2006 and further to 2016, while the prevalence of non‐allergic asthma remained on a stable prevalence level. The prevalence of symptoms common in asthma decreased slightly or was stable despite a substantial decrease in the prevalence of current smoking. Clinicians should be aware that the previously observed increase in prevalence of allergic asthma is still ongoing.

1 May 2005 in Chest
Verified
Journal Article
Closed access
ALAnne Lindberg
Anne Lindberg
AJAnn-Christin Jonsson
Ann-Christin Jonsson
EREva Rönmark
Eva Rönmark
RLRune Lundgren
Rune Lundgren
LLLars-Gunnar Larsson
Lars-Gunnar Larsson
BLBo Lundbäck
Bo Lundbäck

16 September 2005 in Respiration
Verified
Journal Article
Closed access
ALAnne Lindberg
Anne Lindberg
AJAnn-Christin Jonsson
Ann-Christin Jonsson
EREva Rönmark
Eva Rönmark
RLRune Lundgren
Rune Lundgren
LLLars-Gunnar Larsson
Lars-Gunnar Larsson
BLBo Lundbäck
Bo Lundbäck
Background: Guidelines and standards for diagnosis and management of chronic obstructive pulmonary disease (COPD) have been presented by different national and international societies, but the spirometric criteria for COPD differ between guidelines. Objectives: To estimate prevalence of COPD using the guidelines of the British Thoracic Society (BTS), the European Respiratory Society (ERS), the Global Initiative for Chronic Obstructive Lung Disease (GOLD), and the American Thoracic Society (ATS). Further, to evaluate reported airway symptoms, contacts with health care providers, and physician diagnosis of COPD in relation to the respective criteria, and gender differences. Method: In 1992 a postal questionnaire was sent to a random sample of adults aged 20–69 years, 4,851 (85%) out of 5,681 subjects responded. In 1994–1995 a random sample of the responders, 970 subjects, were invited to a structured interview and a lung function test; 666 (69%) participated. Results: The prevalence of COPD was 7.6, 14.0, 14.1, 12.2 and 34.1% according to BTS, ERS, GOLD, clinical ATS (with symptoms or physician diagnosis), and spirometric ATS criteria, respectively. Prevalent COPD was related to age, smoking habits and family history of obstructive airway disease but not to gender. Physician diagnosis of chronic bronchitis or emphysema was only reported by 16.3, 12.2, 11.0, 23.4 and 8.2% of subjects fulfilling the respective criteria, though a majority reported airway symptoms. Conclusion: The main determinants for prevalent COPD were age, smoking habits and spirometric criteria of COPD. Though a majority reported airway symptoms and contact with health care providers due to respiratory complaints, only a minority was diagnosed as having COPD, indicating a large underdiagnosis.